Turn menstrual blood into medical breakthroughs.
Join us in solving conditions impacting billions of people with the power of period blood. Explore some of the conditions we're tackling below.
A pad with a purpose.
Introducing the Q-Pad, the first and only FDA-cleared diagnostic menstrual pad.
We believe all people who menstruate should have the choice to a non-invasive and needle-free way of managing their health. That's why we've crafted the Q-Pad to be conveniently and seamlessly used during menstruation, providing valuable health insights with ease.
Partner with Qvin
THE PROBLEM
Close the women’s health gap:
A $1 trillion opportunity to improve lives and economies worldwide
Source: McKinsey
THE SOLUTION
Qvin’s research shows menstrual blood reliably reveals multiple biomarkers, enabling noninvasive disease diagnosis and monitoring
HARNESSING THE POWER OF THE PERIOD
Within period blood, the untapped opportunity of non-invasive health information awaits
Over 70% of health decisions are made from lab work. Menstrual blood can reveal biomarkers that can replace existing sample collection methods, such invasive biopsies used for endometrial sampling, needles for blood collection, and speculum driven exams for e.g. PAP smears.
Rationale for the Q-Pad
Menstrual blood is an underutilized yet biologically rich fluid containing endometrial cells, immune components, hormones, and protein biomarkers reflective of both gynecological and systemic health. Studies show that menstrual effluent can mirror venous blood biomarker profiles, supporting its use in monitoring metabolic, hormonal, and reproductive conditions [1][2]. The fluid’s unique cytokine and tissue-specific signatures also offer diagnostic potential for conditions like endometriosis and adenomyosis [3][4]. The Q-Pad, a patented, FDA-cleared collection device developed by Qvin, passively collects menstrual blood using an embedded Dried Menstrual Sample strip, enabling individuals to contribute clinically valuable samples from home. Research has demonstrated strong correlations between Q-Pad-collected menstrual blood and venous samples for biomarkers like HbA1c (r = 0.96) and hormones such as TSH and AMH (r > 0.9) [1][5]. By leveraging this accessible, monthly biospecimen, the Q-Pad represents a paradigm shift in women’s health diagnostics—delivering needle-free, at-home testing that expands access and empowers early detection [5].
References
[1] Clinical Validation of Menstrual Blood for the Detection of Hemoglobin A1c and Other Blood-Based Biomarkers, Naseri S et al., Clinical Chemistry, 2023.
[2] Menstrual Blood Contains Cytokine Signatures Reflective of Uterine Immune Environment, van der Veen DR et al., eBioMedicine, 2023.
[3] Identification of Inflammatory and Regulatory Cytokines in Menstrual Effluent as Biomarkers of Endometriosis, Symons LK et al., Reproductive Sciences, 2018.
[4] Proteomic Analysis of Menstrual Effluent Identifies Biomarker Candidates for Endometriosis, Chen JC et al., Scientific Reports, 2022.
[5] Validation of a Menstrual Blood Collection Device for Glycemic Biomarker Analysis: A Non-Invasive Diagnostic Approach, Naseri S et al., Clinical Chemistry, 2023.
JOIN US
Transform the future of health
through menstrual blood research.
Join us in shaping the next generation of diagnostics and women's health.
Funding
If you represent a diagnostic platform, healthcare organization, or country-level agency and would like to work with us, please fill out this form and we will get back to you.
Research
If you are a scientist, foundation, or non-profit interested in collaborating on studies or supporting our innovation, please fill out the form and we will get back to you.